Late-onset late life major depression (late-onset LLMD) is a heterogeneous disorder with respect to etiology and outcome. Both longitudinal and post-mortem studies have found that a subset of elderly individuals with late-onset LLMD who are cognitively intact at the time of their first depressive episode will develop progressive cognitive decline and/or a clinical and histopathologic diagnosis of Alzheimer's disease (AD) within relatively brief follow-up periods. The many decades required for the pathologic AD criteria to develop implies that the depressive episode may represent a preclinical or prodromal phase of AD in a subset of individuals. However, there are presently no biological markers to identify those individuals with late-onset LLMD who have prodromal AD. Results from studies in healthy elderly conducted by our group and others suggest that higher baseline plasma amyloid beta peptide-Ma (A/?42) level, higher A?42/A/?40 ratios and greater reductions in A?42 during longitudinal follow-up, are associated with greater cognitive decline and/or incident AD. There is also evidence from our cross-sectional pilot study of elevated plasma A/?42 and A$42/A?40 ratio in elderly individuals with LLMD, and elevated CSF A/?42 levels have also been reported previously in individuals with major depression. Based on these earlier suggestive findings, the major objectives of this proposal are: (1) to conduct a 3-year longitudinal study to test the hypothesis that elderly individuals with late-onset LLMD will have higher plasma A/942 level and A#42/A?40 ratio and greater reductions in A?42 during longitudinal follow-up relative to controls, and (2) to examine whether measures of A/042 will be associated with greater cognitive decline and/or the development of AD in elderly individuals with late-onset LLMD. Another goal is to determine if changes in plasma A/ff42 levels are paralleled by similar changes in cerebrospinal fluid (CSF) A/?42 in a subset of subjects. If these hypotheses are confirmed, then the determination of plasma A/?42 might become an easily obtainable marker to identify those individuals with late-onset LLMD who may have prodromal AD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH080405-05
Application #
8033160
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Evans, Jovier D
Project Start
2007-03-01
Project End
2014-02-28
Budget Start
2011-03-01
Budget End
2014-02-28
Support Year
5
Fiscal Year
2011
Total Cost
$273,981
Indirect Cost
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Bruno, Davide; Nierenberg, Jay; Cooper, Thomas B et al. (2017) The recency ratio is associated with reduced CSF glutamate in late-life depression. Neurobiol Learn Mem 141:14-18
Agrawal, A; Chou, Y-L; Carey, C E et al. (2017) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry :
Hashimoto, Kenji; Ishima, Tamaki; Sato, Yasunori et al. (2017) Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study. Sci Rep 7:3485
Zhu, Lingxue; Lei, Jing; Devlin, Bernie et al. (2017) TESTING HIGH-DIMENSIONAL COVARIANCE MATRICES, WITH APPLICATION TO DETECTING SCHIZOPHRENIA RISK GENES. Ann Appl Stat 11:1810-1831
Jasinska, Anna J; Zelaya, Ivette; Service, Susan K et al. (2017) Genetic variation and gene expression across multiple tissues and developmental stages in a nonhuman primate. Nat Genet 49:1714-1721
Bruno, Davide; Grothe, Michel J; Nierenberg, Jay et al. (2016) Output order and variability in free recall are linked to cognitive ability and hippocampal volume in elderly individuals. Neuropsychologia 80:126-132
Pomara, Nunzio; Bruno, Davide; Osorio, Ricardo S et al. (2016) State-dependent alterations in cerebrospinal fluid A?42 levels in cognitively intact elderly with late-life major depression. Neuroreport 27:1068-71
Hashimoto, K; Bruno, D; Nierenberg, J et al. (2016) Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study. Transl Psychiatry 6:e744
Bruno, Davide; Grothe, Michel J; Nierenberg, Jay et al. (2015) The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Alzheimers Dement (Amst) 1:81-86
Bruno, Davide; Grothe, Michel J; Nierenberg, Jay et al. (2015) A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia 69:1-8

Showing the most recent 10 out of 16 publications